Tracx Logis TRCX
Tracx Logis: securities offering (amended)
- Form
- F-1/A
- Filed
- Importance
- Routine
- Accession
- 0001213900-26-102048
Not explained yet; the original is on EDGAR.
Securities offering (amended)
What changed since the last draft
30 changes since the F-1/A filed Sep 17, 2026
Compared with the F-1/A 0001213900-26-100785, filed Sep 17, 2026.
Price range: not stated
Price range now not stated; the earlier draft had $18.00 to $22.00.
From the filings
Before
We currently anticipate that the initial public offering price will be between $18.00 and $22.00 per ordinary share.Exchange: not stated
Exchange now not stated; the earlier draft had Nasdaq Global Market.
From the filings
Before
We have applied to list our ordinary shares on the Nasdaq Global Market under the symbol "TRCX"Ticker reserved: not stated
Ticker reserved now not stated; the earlier draft had TRCX.
From the filings
Before
We have applied to list our ordinary shares on the Nasdaq Global Market under the symbol "TRCX"Section removed: About this Prospectus
We and the underwriters have not authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses prepared by or on behalf of…
From the filings
Before
We and the underwriters have not authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses prepared by or on behalf of us or to which we may have referred you. We and the underwriters take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We and the underwriters have not authorized any other person to provide you with different or additional information. We are offering to sell, and seeking offers to buy, ordinary shares only in jurisdictions where such offers and sales are permitted. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of the ordinary shares.Section removed: Conventions that Apply to this Prospectus
Except where the context otherwise requires and for purposes of this prospectus only:
From the filings
Before
Except where the context otherwise requires and for purposes of this prospectus only:Section removed: Presentation of Financial and Other Information
Unless otherwise indicated, all financial information contained in this prospectus is prepared and presented in accordance with International Financial Reporting Standards ("IFRS") as issued by the International…
From the filings
Before
Unless otherwise indicated, all financial information contained in this prospectus is prepared and presented in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB"). Certain differences exist between IFRS and generally accepted accounting principles in the United States of America ("U.S. GAAP") which might be material to the financial information herein. We have not prepared a reconciliation of our consolidated financial statements and related footnote disclosures between IFRS and U.S. GAAP. Potential investors should consult their own professional advisers for an understanding of the differences between IFRS and U.S. GAAP and how these differences might affect the financial information herein.Section removed: Prospectus summary
This summary highlights information contained elsewhere in this prospectus.
From the filings
Before
This summary highlights information contained elsewhere in this prospectus. This summary may not contain all of the information that may be important to you, and we urge you to read this entire prospectus carefully, including the "Risk Factors," "Business" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections and our consolidated financial statements and notes to those statements, included elsewhere in this prospectus, before deciding to invest in our ordinary shares. This prospectus includes forward -looking statements that involve risks and uncertainties. See "Cautionary Statement Regarding Forward -Looking Statements."Section removed: The offering
This summary highlights information contained elsewhere in this prospectus.
From the filings
Before
This summary highlights information contained elsewhere in this prospectus. This summary may not contain all of the information that may be important to you, and we urge you to read this entire prospectus carefully, including the "Risk Factors," "Business" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections and our consolidated financial statements and notes to those statements, included elsewhere in this prospectus, before deciding to invest in our ordinary shares. This prospectus includes forward -looking statements that involve risks and uncertainties. See "Cautionary Statement Regarding Forward -Looking Statements."Section removed: Summary Financial and Other Information
The following summary financial information should be read in conjunction with the sections entitled "Presentation of Financial and Other Information" and "Management's Discussion and Analysis of Financial Condition…
From the filings
Before
The following summary financial information should be read in conjunction with the sections entitled "Presentation of Financial and Other Information" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" and our consolidated financial statements, including the notes thereto, included elsewhere in this prospectus.Section removed: Risk factors
Investing in our ordinary shares involves a high degree of risk.
From the filings
Before
Investing in our ordinary shares involves a high degree of risk. You should carefully consider the following risks and uncertainties and all other information contained in this prospectus before investing in our ordinary shares. Our business, financial condition, results of operations and prospects could be adversely affected as a result of these risks. In that event, the market price of our ordinary shares could decline, and you could lose part or all of your investment. Our business, financial condition, results of operations or prospects could also be harmed by risks and uncertainties not currently known to us or that we currently do not believe are material.Section removed: Forward-looking statements
This prospectus contains "forward -looking statements." Forward -looking statements are based on our beliefs and assumptions and on information currently available to us, and include, without limitation, statements…
From the filings
Before
This prospectus contains "forward -looking statements." Forward -looking statements are based on our beliefs and assumptions and on information currently available to us, and include, without limitation, statements regarding our business, financial condition, strategy, results of operations, certain of our plans, objectives, assumptions, expectations, prospects and beliefs and statements regarding other future events or prospects. Forward -looking statements include all statements that are not historical facts and can be identified by the use of forward -looking terminology such as the words "believe," "expect," "plan," "intend," "seek," "anticipate," "estimate," "predict," "potential," "assume," "continue," "may," "will," "should," "could," "shall," "risk" or the negative of these terms or similar expressions that are predictions of or indicate future events and future trends.Section removed: Use of proceeds
We expect that we will receive net proceeds from this offering of approximately $25.4 million, based on an assumed initial public offering price of $20.00 per share, the mid -point of the estimated range of the initial…
From the filings
Before
We expect that we will receive net proceeds from this offering of approximately $25.4 million, based on an assumed initial public offering price of $20.00 per share, the mid -point of the estimated range of the initial public offering price shown on the cover page of this prospectus, after deducting the underwriting discounts and commissions, non -accountable expense allowance and estimated offering expenses payable by us. If the underwriters exercise their option to purchase additional ordinary shares in full, our net proceeds will be approximately $29.6 million after deducting the underwriting discounts and commissions, non -accountable expense allowance and estimated offering expenses. A $1.00 increase/(decrease) in the assumed initial public offering price of $20.00 per share would increase/(decrease) the net proceeds to us from this offering by approximately $1.4 million, assuming the number of ordinary shares offered by us, as set forth on the cover page of this prospectus, remains the same, and after deducting the underwriting discounts and commissions, non -accountable expense allowance and estimated offering expenses payable by us.
and 18 more, in the redline below
Show the redline
Section by section. Added words and removed words against the earlier filing.
Cover page 61 changes
1 unchanged paragraph
As filed with the U.S. Securities and Exchange Commission on September 17 22 , 2026.
11 unchanged paragraphs
CWT Jurong East Logistic s Centre,
CWT Jurong East Logistics Centre,
17 unchanged paragraphs
This registration statement contains two prospectuses, as set forth below.
• a public offering prospectus (the "Public Offering Prospectus") to be used for the initial public offering of 1,500,000 ordinary shares of the Registrant through the underwriters named in the Underwriting section of the Public Offering Prospectus; and
• a resale prospectus (the "Resale Prospectus") to be used for the potential resale by the Resale Shareholders of an aggregate of 497,344 ordinary shares of the Registrant, which will not be underwritten and sold through the underwriters.
The Resale Prospectus is substantively identical to the Public Offering Prospectus, except for the following principal points:
• they contain different outside and inside front covers;
• the "Prospectus Summary — The Offering" section in the Public Offering Prospectus is removed and replaced with the Offering section on page Alt -1 of the Resale Prospectus;
• they contain different Use of Proceeds sections;
• a Resale Shareholders section is included in the Resale Prospectus beginning on page Alt -3 of the Resale Prospectus;
• the "Capitalization" and "Dilution" sections in the Public Offering Prospectus are deleted from the Resale Prospectus;
• references in the Public Offering Prospectus to the Resale Prospectus will be deleted from the Resale Prospectus;
• the "Underwriting" section in the Public Offering Prospectus is removed and replaced with a Plan of Distribution section on page Alt -4 of the Resale Prospectus;
• the "Legal Matters" section in the Public Offering Prospectus is removed and replaced with the Legal Matters section on page Alt -6 of the Resale Prospectus; and
• the outside back cover of the Public Offering Prospectus is deleted from the Resale Prospectus.
The Registrant has included in this Registration Statement, after the financial statements, a set of alternate pages (the "Alternate Pages") to reflect the foregoing differences of the Resale Prospectus as compared to the Public Offering Prospectus.
The Public Offering Prospectus will exclude the Alternate Pages and will be used for the public offering by the Registrant. The Resale Prospectus will be substantively identical to the Public Offering Prospectus, except for the addition or substitution of the Alternate Pages and will be used for the resale offering by the Resale Shareholders.
The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and we are not soliciting offers to buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject to Completion dated September 17 , 2026
PRELIMINARY PROSPECTUS
1,500,000 ORDINARY SHARES
This is the initial public offering of Tracx Logis Ltd. We are offering 1,500,000 ordinary shares.
Prior to this offering, there has been no public market for our ordinary shares. We currently anticipate that the initial public offering price will be between $18.00 and $22.00 per ordinary share.
We have applied to list our ordinary shares on the Nasdaq Global Market under the symbol "TRCX"
In addition, we are registering an aggregate of 497,344 ordinary shares for resale by certain Resale Shareholders by means of the Resale Prospectus. The Resale Shareholders in the resale offering may not commence the resale of their shares pursuant to the Resale Prospectus until after our primary offering closes.
We are both an "emerging growth company" and a "foreign private issuer" under applicable U.S. Securities and Exchange Commission rules and will be eligible for reduced public company reporting requirements.
Although we are a Singapore incorporated company and the majority of our operations are not in the PRC and Hong Kong, we are exposed to legal and operational risks associated with our operations in the PRC and Hong Kong. The PRC government has significant authority to exert influence on the ability of a company with operations in the PRC and Hong Kong, including us, to conduct its business, and may intervene with or influence our operations in the PRC and Hong Kong as the government deems appropriate to further regulatory, political and societal goals. Changes in China's economic, political or social conditions or government policies could materially and adversely affect our business and results of operations in the PRC and Hong Kong. On February 17, 2023, the China Securities Regulatory Commission (the "CSRC") released a set of regulations consisting of six documents, including the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies and five supporting guidelines, which came into effect on March 31, 2023 (collectively, the "Filing Measures"). Based on consultation with our PRC counsel, we believe we are not subject to filing requirements with the CSRC under the Filing Measures with respect to the issuance of our ordinary shares as of the date of this prospectus, because (i) none of the operating revenue, total profits, total assets, or net assets of our PRC subsidiaries in the most recent fiscal year has exceeded 50% of the relevant data in the audited consolidated financial statements of our company for the same period, (ii) the main aspects of our business activities are not carried out within the PRC and the primary locations of our business operations are not within the PRC, and (iii) the senior management responsible for our daily operations are not PRC citizens or habitually resident in the PRC. In addition, we believe our operations and this offering are not subject to review or prior approval by the Cyberspace Administration of China (the "CAC"). However, as the Filing Measures are relatively new, there exists uncertainty with respect to the further implementation and interpretation of the principle of "substance over form." If we later find out that we and/or our PRC subsidiaries were to be required to obtain any permission or approval from or were required to complete any filing procedure with the CSRC, the CAC, or other PRC governmental authorities in connection with this offering under PRC law, we and/or our PRC subsidiaries may be fined or subject to other sanctions, and our PRC subsidiaries' business and our reputation, financial condition, and results of operations may be materially and adversely affected. In addition, we face risks associated with the interpretation and application of PRC laws and regulations relating to anti -monopoly , cybersecurity, data privacy and data protection, and related regulatory actions and oversight. The PRC has recently made a number of public statements and initiated regulatory developments relating to cybersecurity, data privacy and anti -monopoly . As PRC laws and regulations in these areas are evolving, there remain uncertainties as to the interpretation, application and enforcement of existing and future laws, regulations, rules and implementation measures, including whether and how such laws, regulations and regulatory developments would apply to us, and the potential impact they will have on our daily business operation in the PRC, our ability to accept foreign investments, and our ability to offer or continue to offer securities to investors on a U.S. or other foreign securities exchange, and list or continue to maintain our listing on a U.S. or other foreign exchanges. Any such action or oversight, to the extent applicable to us and which cannot be addressed favorably by us, could materially impact our business, operations and financial performance in the PRC and Hong Kong and could significantly limit or completely hinder our ability to offer or continue to offer securities to investors and cause the value of our securities to significantly decline or in extreme cases, become worthless.
For additional detail on these and other risks, see "Risk Factors — Risks Relating to Doing Business in the PRC and Hong Kong" starting on page 36 of this prospectus.
Tracx Logis Ltd. operates its business in Singapore directly and in various other jurisdictions through its wholly -owned subsidiaries, their respective branches and certain associates (which, under IFRS, are entities in which we have a significant shareholding such that we have significant influence but do not have the requisite shareholding to control). We do not have any variable interest entities ("VIEs") in China or in any other jurisdiction, except in Indonesia where we have one entity accounted for as a VIE. This VIE has been dormant from an operational perspective since 2024 and is not material to our business, operations and financial position, and there are no shareholder loans to this VIE. We expect to dissolve or put into voluntary liquidation such VIE by the end of 2026. Cash is transferred between and among Tracx Logis and its subsidiaries through capital contributions, dividends, intercompany loans or payments for intercompany sales and services in the ordinary course of business. We do not intend to distribute earnings or settle amounts owed under any agreement other than the agreements entered into in the ordinary course of business for the intercompany transactions, such as sales of products and services and executive compensation. In the years ended December 31, 2024 and 2025, the following cash transfers have been made between Tracx Logis and its subsidiaries: (a) in 2024, Tracx Logis (i) did not make any capital contribution; (ii) made intercompany loans in an aggregate amount of S$0.8 million to KCI and an aggregate amount of S$0.6 million to other subsidiaries of Tracx Logis; (iii) received repayment of intercompany loans in the amount of S$1.3 million from KCI, and repayment of loan in the amount of S$2.3 million from its subsidiary in Japan; (iv) obtained intercompany loans in an aggregate amount of S$2.7 million from KCI and its subsidiaries, and (v) repaid intercompany loans in an aggregate amount of S$0.6 million to KCI and its subsidiaries, and intercompany loans in an aggregate amount of $0.5 million to its subsidiary in Korea, and (b) in 2025, Tracx Logis (i) did not make any capital contribution; (ii) made intercompany loans in an aggregate amount of S$7.8 million to its subsidiary in Korea; (iii) received repayment of loans in the amounts of S$4.4 million from its subsidiary in Korea; and (iv) repaid intercompany loans in an aggregate amount of S$1.2 million to KCI.
As of the date of this prospectus, neither Tracx Logis nor any of its subsidiaries has ever paid dividends or made distributions to any U.S. investors or any other shareholders.
Investing in our ordinary shares involves risks. Please read "Risk Factors" beginning on page 19.
(1) Does not include a non -accountable expense allowance equal to 1.0% of the public offering price. We have also agreed to reimburse certain expenses of the underwriters and to issue to the underwriters warrants to purchase up to a total of 5% of the ordinary shares sold in the offering. Such warrants and underlying shares are included in this prospectus. For additional information on underwriting compensation, see "Underwriting."
(2) Represents proceeds before expenses.
We have granted the underwriters an option to purchase up to 225,000 ordinary shares for a period of 45 days from the date of this prospectus to cover over -allotments at the initial public offering price less the underwriting discount.
Neither the Securities and Exchange Commission nor any state securities regulators have approved or disapproved these securities, or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The underwriters expect to deliver the ordinary shares against payment on 2026.
Roth Capital Partners
Revere Securities LLC
About this Prospectus
Conventions that Apply to this Prospectus
Presentation of Financial and Other Information
Market and Industry Data
Summary Financial and Other Information
Cautionary Statement Regarding Forward-Looking Statements
Dividends and Dividend Policy
Selected Financial and Other Information
Management's Discussion and Analysis of Financial Condition and Results of Operations
Certain Relationships and Related Party Transactions
Principal Shareholders
Description of Share Capital
Shares Eligible for Future Sale
Expenses of the Offering
Service of Process and Enforcement of Civil Liabilities
Where You Can Find More Information
Index to the Consolidated Financial Statements
No dealer, salesperson or other person is authorized to give any information or to represent anything not contained in this prospectus or in any free writing prospectus we may authorize to be delivered or made available to you. You must not rely on any unauthorized information or representations. This prospectus is an offer to sell only the shares offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus is current only as of its date.
Neither we nor the underwriters have done anything that would permit this offering or possession or distribution of this prospectus or any filed free writing prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside of the U.S. who come into possession of this prospectus or any filed free writing prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares and the distribution of this prospectus or any filed free writing prospectus outside of the U.S.
Until [ ], 2026 (the 25 th day after the date of this prospectus), all dealers that buy, sell or trade our ordinary shares, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the obligation of dealers to deliver a prospectus when acting as the underwriter and with respect to its unsold allotments or subscriptions.
This Amendment No. 2 is being filed solely for the purpose of filing Exhibits 1.1, 4.2, 5.1, 5.2 and 10.4 to this registration statement on Form F -1 , or the Registration Statement, and to amend and restate the exhibit index set forth in Part II of the Registration Statement. No change is made to the preliminary prospectus constituting Part I of the Registration Statement. This Amendment No. 2 does not contain copies of the prospectus included in the Registration Statement, which remains unchanged from Amendment No. 1 to the Registration Statement filed on September 17, 2026, and consists only of the cover page of the Registration Statement, this explanatory note and Part II of the Registration Statement.
INFORMATION NOT REQUIRED IN PROSPECTUS
Exhibits 4 changes
4 unchanged paragraphs
Form of Underwriter Warrant*
** Previously filed.
Form of Representative Warrant
Opinion of Allen Overy Shearman Sterling LLP as to the validity of the Ordinary Shares 5.2 Opinion of Allen Overy Shearman Sterling as to enforceability of Underwriter Warrants 10.1 Tracx Logis Employee Stock Option Plan** 10.2 English Translation of Lease Agreement for Arenas Yeongjong Logistics Center in Incheon, Korea** 10.3 Lease Agreement for Jurong East Logistics Centre, Singapore** 10.4 Financial Advisory Agreement (including form of Warrant) 21.1 List of Subsidiaries (updated)** 23.1 Consent of Marcum Asia CPAs LLP** 23.2 Consent of Allen Overy Shearman Sterling LLP (included in Exhibit 5.1) 23.3 Consent of Global Law Office** 23.4 Consent of Vuk Jeremi ć** ** 23.5 Consent of Samuel Shin Chul Park ** 23.6 Consent of Matthew J. Saker ** 24.1 Power of Attorney (included on signature page to the registration statement filed on July 28, 2026) ** 24.2 Power of Attorney of Koh Lian Peng (included on signature page hereto) to the registration statement filed on September 17, 2026)** 99.1 Code of Business Conduct and Ethics of the Registrant ** Filing Fee Table ** ____________ To be ** Previously filed. by amendment.
Undertakings 3 changes
5 unchanged paragraphs
Pursuant to the requirements of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F -1 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Singapore, on September 17, 22, 2026.
1 unchanged paragraph
The undersigned director of Tracx Logis Ltd. hereby constitutes and appoints Mr. Mark Lee and Mr. Peter Kim, and each of them singly (with full power to each of them to act alone), our true and lawful attorneys -in -fact and agents, with full power of substitution and resubstitution in each of them for him and in his name, place and stead, and in any and all capacities, to sign any and all amendments (including post -effective amendments) to this Registration Statement (or any other Registration Statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys -in -fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as full to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys -in -fact and agents or any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.
9 unchanged paragraphs
Pursuant to the Securities Act, the undersigned, the duly authorized representative in the United States of Tracx Logis Ltd., has signed this registration statement or amendment thereto in New York City, New York, United States on September 17, 22, 2026.
2 unchanged paragraphs
Unchanged: Indemnification of Directors and Officers, Recent Sales of Unregistered Securities
Only in the earlier filing: About this Prospectus, Conventions that Apply to this Prospectus, Presentation of Financial and Other Information, Market and Industry Data, Prospectus summary, The offering, Summary Financial and Other Information, Risk factors, Forward-looking statements, Use of proceeds, Dividends and Dividend Policy, Capitalization, Dilution, Selected Financial and Other Information, MD&A, Business, Regulation, Management, Related-party transactions, Principal stockholders, Description of the securities, Shares Eligible for Future Sale, Tax Considerations, Plan of distribution, Expenses of the Offering, Legal Matters, Experts, Service of Process and Enforcement of Civil Liabilities, Where You Can Find More Information, Index to the Consolidated Financial Statements, Notes to the financial statements, Note 1: General information, Note 1: General information (cont.), Note 2: Summary of significant accounting policies, Note 2: Summary of significant accounting policies (cont.), Note 3: Critical accounting estimates, assumptions, and judgments, Note 4: Segment information, Note 4: Segment information (cont.), Note 5: Revenue from contracts with customers, Note 5: Revenue from contracts with customers (cont.), Note 6: Breakdown of expenses by nature, Note 7: Finance income — net, Note 8: Other income (losses) — net, Note 9: Income tax expense, Note 9: Income tax expense (cont.), Note 10: Other non -current liabilities, Note 11: Loss per share, Note 12: Cash and cash equivalents and short -term financial assets, Note 13: Trade and other receivables, Note 13: Trade and other receivables (cont.), Note 14: Inventories, Note 15: Other current assets, Note 16: Property, plant and equipment, Note 17: Lease — The Group as a lessee, Note 17: Lease — The Group as a lessee (cont.), Note 18: Intangible assets, Note 18: Intangible assets (cont.), Note 19: Investment in associates (cont.), Note 20: Financial asset at fair value through other comprehensive income, Note 21: Trade and other payables, Note 22: Borrowings, Note 22: Borrowings (cont.), Note 23: Employee benefit obligations, Note 23: Employee benefit obligations (cont.), Note 24: Other liabilities, Note 25: Commitments and contingencies, Note 26: Share capital, Note 26: Share capital (cont.), Note 27: Share -based payments, Note 27: Share-based payments (cont.), Note 28: Other reserves, Note 28: Other reserves (cont.), Note 29: Financial risk management, Note 29: Financial risk management (cont.), Note 30: Financial value measurement, Note 30: Financial value measurement (cont.), Note 31: Statements of cash flows, Note 31: Statements of cash flows (cont.), Note 32: Related party transactions, Note 32: Related party transactions (cont.), Note 33: Convertible notes, Note 33: Convertible notes (cont.), Note 34: Events occurring after reporting period, Note 35: Other events occurring after reporting period
Compared by code from the two drafts’ text: offering terms first, then sections and risk factors added or removed, numbers that moved, and rewording. No model wrote this list. Not investment advice.
Similar companies
Companies of similar size in SIC 4210 and related industry codes: the same peer list as the financial tables.
- Elite Express Holding ETS public float $2M, Feb 26, 2026
- BingEx FLX
- Haoxin Holdings HXHX
- Shengfeng Development SFWL
- TFI International TFII